Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing

This study is beta-testing a digital tool designed to help patients newly diagnosed with acute leukemia (a fast-moving blood cancer) better understand their diagnosis, treatment options, and what to expect — with a focus on reducing health inequities. **You may be eligible if...** - You are 18 or older - You speak English - You are admitted to a Dana-Farber Cancer Institute affiliated hospital with a suspected or confirmed diagnosis of acute leukemia - You are able to participate in in-person testing of the app **You may NOT be eligible if...** - You have a cognitive impairment that would prevent you from using or evaluating the app - You are under 18 - You are currently incarcerated - You participated in the earlier alpha-testing phase of this tool Talk to your doctor to see if this trial is right for you.